Image Guided Therapy in the Treatment of Gliomas

NCT01263821 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2017-08-04

No results posted yet for this study

Summary

RATIONALE: New imaging techniques using magnetic resonance imaging give better tumor definition, thus may lead to better tumor targeting and avoid damaging critical parts of normal brain.

PURPOSE: This phase I/II trial is studying how well image-guided therapy works in treating patients with newly diagnosed intracranial glioma.

Conditions

Interventions

PROCEDURE

Diffusion-weighted magnetic resonance imaging

Undergo diffusion-weighted MRI

PROCEDURE

Perfusion-weighted magnetic resonance imaging

Undergo perfusion-weighted magnetic resonance imaging

PROCEDURE

Functional magnetic resonance imaging

Undergo functional MRI

PROCEDURE

Magnetic resonance spectroscopic imaging

Undergo MR spectroscopic imaging

PROCEDURE

Therapeutic conventional surgery

Undergo maximal surgical resection

PROCEDURE

Quality-of-life assessment

Ancillary studies

PROCEDURE

Radiation therapy treatment planning/simulation

Undergo IMRT planning

PROCEDURE

Intensity-modulated radiation therapy

Undergo intensity-modulated radiation therapy

OTHER

Questionnaire administration

Ancillary studies

Sponsors & Collaborators

Principal Investigators

  • Joshua Silverman, MD · NYU Langone Health

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01263821 on ClinicalTrials.gov